LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


LSPedia Compliance Briefing | September 2025
Whether you're a manufacturer, wholesaler, repackager, 3PL, or dispenser, DSCSA compliance is not a theoretical future anymore. It's operational reality.
For proof, consider these findings from LSPedia’s August 2025 DSCSA Industry Survey:
Among all governing bodies, state boards are leading the inspection activities at 11.76%, followed by the FDA (9.8%), “other agencies” (7.84%), and the NABP (5.88%).
We get it—compliance can feel like red tape. But in the pharmaceutical supply chain, it's also the backbone of trust, safety, and operational efficiency. The DSCSA is now in full effect, and unless you’re covered by a specific, narrow FDA exemption, it’s time to get your systems live, your data flowing, and your teams trained.
Let’s break it down with some insight and recommendations.
If your business buys or sells prescription drugs in the U.S., you’re subject to DSCSA requirements. That includes:
If you're still relying on old systems or paper-based workflows, you're officially out of synch with the industry and in danger of incurring penalties and audits. The key requirements—serialization, authorized trading partner verification, suspect product handling, and electronic data exchange—are live and enforceable.
Yes, the FDA granted a few time-limited exemptions. Here’s where they stand:
If you're not squarely in one of those categories with a current exemption, you are already expected to be 100% compliant.

Since November 27, 2023, all prescription drug transactions must include package-level data. That means:
Put simply: If you don’t receive EPCIS data, you can’t accept the product. No data? No business.
Verification isn’t just a buzzword. It’s your legal obligation.
If your business can’t detect suspect or illegitimate product, or if you can’t respond to a verification request, you’re out of compliance and exposing yourself to serious risk. The bare minimum today includes:
Cut-and-paste SOPs from Google are not allowed. Regulators want to see systems that are implemented, tested, and used—not shelved.
If you think the FDA and state boards are still in education mode, think again. Federal enforcement includes the following:

This is no longer hypothetical. Enforcement is happening—and it’s accelerating.
There’s still a lot of confusion out there. Let’s set the record straight.

What’s at stake if you fall behind? Failure to comply with DSCSA may result in:
Regulators demand it. Your customers expect compliance, too. If you aren't complying with the law, that could become evidence of negligence in private lawsuits.
Pharmacies are the last milestone of the DSCSA enforcement. Big changes are coming to them:
One real-world example: if you bought a drug from Distributor A, you can’t return it to Distributor B, even if it’s the same NDC. You need to have a system in place to meet compliance and avoid costly mistakes.
You don’t have to solve DSCSA on your own. Our platform is built for this moment.
Whether you're just starting your DSCSA compliance journey, facing resource shortages, sorting out EPCIS exceptions, dealing with shipment quarantines, or optimizing your live environment, we have the experience, solutions, and people to help.
We’ve helped 1,500 companies get ready. We can help you, too. Let’s put your compliance program into high gear, without slowing down your business.
If you’re not sure where to begin, start by reaching out. We’ll show you how to get it done—fast, affordably, and with zero guesswork.